Deregulated expression of p27(Kip1) in human breast cancers

Clinical Cancer Research

Volumn 3, Issue 10, 1997, Pages 1879-1887

  Sgambato, Alessandro ^b   Zhang, Yu Jing ^a   Arber, Nadir ^a   Hibshoosh, Hanina ^a   Doki, Yuichiro ^a   Ciaparrone, Marco ^b   Santella, Regina M ^a   Cittadini, Achilles ^b   Weinstein, I Bernard ^a,c  

^a College of Physicians and Surgeons ^*  (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TRANSFORMED; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0030814482     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. 1 cyclins. Curr. Opin. Cell Biol., 6: 842-846, 1994.
2. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
3. Sherr, C. J. D-type cyclins. Trends Biochem. Sci., 20: 187-190, 1995.
4. Elledge, S. J., and Harper, J. W. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol., 6: 847-852, 1994.
5. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
6. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
7. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
8. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type Rb function. Genes Dev., 8: 2939-2952, 1994.
9. Hirai, H., Roussel, M. F., Kato, J., Ashmun, R. A., and Sherr, C. J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15: 2672-2681, 1995.
10. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
11. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
12. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev., 9: 639-649, 1995.
13. Sdi1/CIP1/WAF1. EMBO J., 14: 555-563, 1995.
14. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S. I., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in the genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
15. Jen, J., Harper, W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., and Vogelstein, B. Deletion of p15 and p16 in brain tumors. Cancer Res., 54: 6353-6358, 1994.
16. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
17. Serrano, M., Lee, H-W., Chin, L., Cordon-Cardo, C., Beach, D., and De Phino, R. A. Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85: 27-37, 1996.
18. Kip1, to regions involved in human cancer. Cancer Res., 55: 1199-1205, 1995.
19. Kip1 in primary breast carcinomas. Hum. Genet., 97: 91-94, 1996.
20. Kawamata, N., Morosetti, R., Miller, C. W., Park, D., Spirin, K. S., Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson, J., Wilczynski, S., Lee, Y. Y., Bartram, C. R., and Koeffler, H. P. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55: 2266-2269, 1995.
21. Kip1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood, 86: 1924-1930, 1995.
22. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res., 55: 1206-1210, 1995.
23. Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res., 55: 1211-1214, 1995.
24. Spirin, K. S., Simpson, J. F., Takeuchi, S., Kawamata, N., Miller, C. W., and Koeffler, H. P. p27/Kip1 mutations found in breast cancer. Cancer Res., 56: 2400-2404, 1996.
25. Shiohara, M., El-Deiry, W. S., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D-L., Vogelstein, B., and Koeffler, H. P. Absence of WAF1 mutations in a variety of human malignancies. Blood, 84: 3781-3784, 1994.
26. Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., and Hannon, G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-557, 1995.
27. 1 checkpoint control. Cell, 82: 675-684, 1995.
28. Kip1-deficient mice. Cell, 85: 733-744, 1996.
29. Kip1. Cell, 85: 721-732, 1996.
30. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707-720, 1996.
31. KIP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
32. Soos, T. J., Kiyokawa, H., Yan, J. S., Rubin, M. S., Giordano, A., DeBlasio, A., Bottega, S., Wong, B., Mendelsohn, J., and Koff, A. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ., 7: 135-146, 1996.
33. KIP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
34. Reynisdottir, I., Polyak, K., Iavarone, A., and Massague, J. Kip/Cip and INK4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-B. Genes Dev., 9: 1831-1845, 1995.
35. Keyomarsi, K., and Pardee, A. B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA, 90: 1112-1116, 1993.
36. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H. J., and Pardee, A. B. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54: 380-385, 1994.
37. Keyomarsi, K., Conte, D., Jr., Toyofuku, W., and Fox, M. P. Deregulation of cyclin E in breast cancer. Oncogene, 11: 941-950, 1995.
38. Kip1. Cancer Res., 56: 1389-1399, 1996.
39. Clurman, B. E., Sheaff, R. J., Thress, K., Groudine, M., and Robertys, J. M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev., 10: 1979-1990, 1996.
40. Kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ., 7: 699-710, 1996.
41. Kitahara, K., Yasui, W., Yokozaki, H., Semba, S., Hamamoto, T., Hisatsugu, T., and Tahara, E. Expression of cyclin D1, CDK4 and p27Kip1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines. J. Exp. Ther. Oncol., 1: 7-12, 1996.
42. Soule, H., Maloney, T. M., Wolman, S. R., Peterson, W. D., Jr., Brenz, R., McGrath, C. M., Russo, J., Pauly, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6075-6086, 1990.
43. Stampfer, M. R., and Bartley, J. C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. USA, 82: 2394-2398, 1985.
44. Zwijsen, R. M. L., Klompmaker, R., Wientjens, E. B. H. G. M., Kristel, P. M. P., van der Burg, B., and Michalides, R. J. A. M. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol. Cell. Biol., 16: 2554-2560, 1996.
45. American Joint Committee on Cancer. Breast. In: O. H. Beahrs, D. E. Henson, R. V. P. Hutter, and B. J. Kennedy (eds.), Manual for Staging of Cancer, Ed. 4, pp. 149-154. Philadelphia: J. B. Lippincott, 1992.
46. Jiang, W., Zhang, Y-J., Kahn, S. M., Hollestein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R., and Weinstein, I. B. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 90: 9026-9030, 1993.
47. Caron de Fromentel, C., Nardeux, P. C., Soussi, T., Lavialle, C., Estrade, S., Carloni, G., Chandrasekaran, K., and Cassingena, R. Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information. Exp. Cell Res., 160: 83-94, 1985.
48. Han, E. K., Sgambato, A., Jiang, W., Zhang, Y., Santella, R. M., Doki, Y., Cacace, A. M., Schieren, I., and Weinstein, I. B. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene, 10: 953-962, 1995.
49. 1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats. Cell Growth Differ., 7: 1571-1578, 1996.
50. Kip1 protein: prognostic implications in primary breast cancer. Nat. Med., 3: 227-230, 1997.
51. Barbareschi, M., Caffo, O., Doglioni, C., Fina, P., Marchetti, A., Buttitta, F., Leek, R., Morelli, L., Leonardi, E., Bevilacqua, G., Dalla Palma, P., and Harris, A. L. p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br. J. Cancer, 74: 208-215, 1996.
52. Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., and Roberts, J. M. Expression of cell-cycle regulators p27 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med., 3: 222-225, 1997.
53. Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentino, M., Draetta, G. F., Jessup, J. M., and Pagano, M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med., 3: 231-233, 1997.
54. Kip1 protein in human breast carcinoma: immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues. Proc. Am. Assoc. Cancer Res., 38: 497, 1997.
55. Kip1 suppressor gene mRNA and protein expression in early and frank renal tumors induced by estrogen in Syrian hamsters. Proc. Am. Assoc. Cancer Res., 38: 496, 1997.
56. Kip1 on resistance of tumor cells to anticancer agents. Nat. Med., 2: 1204-1210, 1996.
57. Kip1 is associated with enhanced survival under three-dimensional growth conditions during melanoma progression. Proc. Am. Assoc. Cancer Res., 38: 496, 1997.